PolyPeptide Group AG (SWX:PPGN)

PolyPeptide Group AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	76.7	68.28	95.71	37.53	136.3	17.21
Cash & Short-Term Investments	76.7	68.28	95.71	37.53	136.3	17.21
Cash Growth	58.22%	-28.66%	155.03%	-72.47%	692.09%	-1.71%
Accounts Receivable	57.49	86.26	78.78	49.15	67.79	55.54
Other Receivables	9.4	21.2	17.21	13.27	8.14	9.6
Receivables	66.89	107.46	95.98	62.41	75.92	65.14
Inventory	157.68	146.35	128.51	145.07	113	94.27
Prepaid Expenses	-	5.99	5.09	5	4.75	2.53
Other Current Assets	18.56	0.14	1.32	1.56	1.63	0.72
Total Current Assets	319.83	328.22	326.6	251.57	331.61	179.86
Property, Plant & Equipment	410.57	388.99	324.11	297.29	235.44	169.81
Long-Term Investments	6.23	5.16	5.24	2.77	3.47	0.2
Other Intangible Assets	13.89	15.02	16.45	15.87	14.27	12.56
Long-Term Deferred Tax Assets	21	17.62	16.69	8.29	10.26	13.55
Long-Term Deferred Charges	1.56	1.56	-	-	-	-
Total Assets	773.07	756.58	689.09	575.78	595.04	375.98
Accounts Payable	67.2	73.26	60.91	45.93	28.48	28.36
Accrued Expenses	-	22.54	24.02	17.19	20.48	18.71
Current Portion of Long-Term Debt	1.93	31.91	42.48	1.1	1.15	3.5
Current Portion of Leases	4.56	5.07	4.45	3.57	3.06	1.98
Current Income Taxes Payable	1.81	0.36	0.23	0.07	4	8.28
Current Unearned Revenue	88.52	60.48	42.97	27.54	46.13	34.07
Other Current Liabilities	32.91	0.89	1.39	0.66	0.67	6.96
Total Current Liabilities	196.92	194.5	176.45	96.05	103.96	101.85
Long-Term Debt	88.33	48.93	58.98	9.41	10.3	35.9
Long-Term Leases	16.5	18.98	18.87	17.65	14.95	10.45
Long-Term Unearned Revenue	105.53	99.64	23.16	-	-	-
Long-Term Deferred Tax Liabilities	2.94	3.21	3.64	1.88	1.11	0.88
Other Long-Term Liabilities	1.78	1.94	1.65	2.48	4.57	10.11
Total Liabilities	442.08	399.33	307.86	154.11	173.87	198.32
Common Stock	0.3	0.3	0.3	0.3	0.3	33
Additional Paid-In Capital	203.13	203.13	203.13	203.13	212.8	2.34
Retained Earnings	116.18	140.48	165.14	214.15	196.03	147.94
Treasury Stock	-7.45	-8.4	-10.39	-13.61	-1.19	-
Comprehensive Income & Other	18.83	21.73	23.05	17.71	13.23	-5.62
Shareholders' Equity	330.99	357.24	381.23	421.68	421.17	177.66
Total Liabilities & Equity	773.07	756.58	689.09	575.78	595.04	375.98
Total Debt	111.32	104.89	124.78	31.72	29.45	51.83
Net Cash (Debt)	-34.62	-36.61	-29.08	5.8	106.85	-34.62
Net Cash Growth	-	-	-	-94.57%	-	-
Net Cash Per Share	-1.04	-1.11	-0.88	0.18	3.33	-1.15
Filing Date Shares Outstanding	32.99	33	32.97	32.93	33.1	30
Total Common Shares Outstanding	32.99	33	32.97	32.93	33.1	30
Working Capital	122.9	133.72	150.15	155.52	227.65	78.01
Book Value Per Share	10.03	10.83	11.56	12.81	12.72	5.92
Tangible Book Value	317.1	342.23	364.77	405.81	406.91	165.1
Tangible Book Value Per Share	9.61	10.37	11.06	12.33	12.29	5.50
Land	-	147.37	129.94	124.02	87.67	94.66
Machinery	-	319.26	243.43	201.16	170.55	138.83
Construction In Progress	-	88.43	91.17	98.64	87.4	49.57

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.